Plain-English translation of NCT07480915 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This is an observational study that will follow 160 patients with heart failure and coronary artery disease who are having coronary artery bypass grafting (bypass surgery). Researchers want to learn whether a blood marker called GDF-15, measured before your surgery, can help doctors predict which patients are more likely to have serious heart problems after surgery.
Currently, doctors don't have a reliable way to identify which heart failure patients will have the worst outcomes after bypass surgery. By studying GDF-15 levels before surgery, researchers hope to develop a simple blood test that can help doctors identify high-risk patients earlier and provide them with better care.
You likely qualify if…
You likely don't qualify if…
If you join, you'll have a blood sample taken from your arm the morning before your bypass surgery—that's the main study requirement. Researchers will also follow your health for 12 months after surgery with one in-person visit at the end, or a phone call if you can't visit the clinic. All other care you receive is standard treatment for your condition.
AI-generated summary from trial data · Aug 15, 2026 · Not medical advice
Russia